完善个人信息
取消
| | CAS号 | | 英文名称 | | 中文名称 | | 分子式 | | 分子量 |
|---|---|---|---|---|
| 2252345-81-4 | Vaccarin E | Vaccarin E | C42H48O22 | 904.82 |
| 508233-82-7 | Vortioxetine Impurity 3 | 沃替西汀杂质3 | C17H20N2S | 284.42 |
| 1417529-67-9 | Vardenafil IMpurity 1 | 伐地那非杂质1 | C17H18N4O4 | 342.35 |
| 152708-24-2 | Valsartan Impurity 32 | 缬沙坦杂质34 | C14H11N7 | 277.28 |
| 1378391-44-6 | Velpatasvir intermediate | 叔丁基 (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(甲氧基羰基)-L-缬氨酰]-5-甲基吡咯烷-2-基}-1,4,5,11-四氢异吡喃[4′,3′:6,7]萘并[1,2-D]咪唑-9-基)-1H-咪唑-2-基]-4-(甲氧基甲基)吡咯烷-1-羧酸 | C44H55N7O7 | 793.95 |
| 1378391-43-5 | Velpatasvir intermediate | 维帕他韦中间体VP N-3 | C44H55N3O13 | 833.92 |
| 1789703-36-1 | Vildagliptin Related Compound F | 维格列汀杂质F | C17H24N2O3 | 304.38 |
| 1431280-51-1 | VLX1570 | CS-2226 | C23H17F2N3O6 | 469.39 |
| 1036959-27-9 | Vildagliptin (2R)-Isomer | (2R)-1-[2-[(3-羟基金刚烷-1-基)氨基]乙酰基]-2-吡咯烷甲腈 | C17H25N3O2 | 303.4 |
| 644981-35-1 | Val-Cit-PAB-MMAE | VAL-CIT-PAB-OH | C58H94N10O12 | 1123.42676 |
